Antagonist binding profiles of five cloned human muscarinic receptor subtypes.

Article Details

Citation

Dorje F, Wess J, Lambrecht G, Tacke R, Mutschler E, Brann MR

Antagonist binding profiles of five cloned human muscarinic receptor subtypes.

J Pharmacol Exp Ther. 1991 Feb;256(2):727-33.

PubMed ID
1994002 [ View in PubMed
]
Abstract

A variety of muscarinic antagonists are currently used as tools to pharmacologically subclassify muscarinic receptors into M1, M2 and M3 subtypes. In the present study, we have determined the affinity profiles of several of these antagonists at five cloned human muscarinic receptors (m1-m5) stably expressed in Chinese hamster ovary cells (CHO-K1). At all five receptors, the (R)-enantiomers of trihexyphenidyl and hexbutinol displayed considerably higher affinities (up to 525-fold) than their corresponding (S)-isomers. The stereoselectivity ratios [inhibition constant(S)/inhibition constant(R)] for both pairs of enantiomers were lowest at m2 receptors, suggesting that less stringent configurational demands are made by this receptor subtype. The "M1-selective" antagonist (R)-trihexyphenidyl displayed high affinities for m1 and m4 receptors. The "M2-selective" antagonists himbacine, (+-)-5,11-dihydro-11- ([(2-[(dipropylamino)methyl]-1- piperidinyl)ethyl)amino]carbonyl)-6H-pyrido(2,3-b)(1,4)benzodiazepine-6- one (AF-DX 384), 11-[4-[4-(diethylamino)butyl]-1-piperidinyl)acetyl)-5,11- dihydro-6H-pyrido(2,3-b) (1,4)benzodiazepine-6-one (AQ-RA 741) and (+)-(11-[2-[(diethylamino) methyl]-1-piperidinyl)acetyl)-5,11-di-hydro-6H-pyrido(2,3-b)(1,4) benzodiazepine-6-one [AF-DX 250; the (+)-enantiomer of AF-DX 116] exhibited high affinities for m2 and m4, intermediate affinities for m1 and m3 and low affinities for m5 receptors. This selectivity profile was most prominent for AQ-RA 741, which displayed 195- and 129-fold higher affinities for m2 and m4 receptors than for m5 receptors.(ABSTRACT TRUNCATED AT 250 WORDS)

DrugBank Data that Cites this Article

Drug Targets
DrugTargetKindOrganismPharmacological ActionActions
TrihexyphenidylMuscarinic acetylcholine receptor M1ProteinHumans
Yes
Antagonist
Details
TrihexyphenidylMuscarinic acetylcholine receptor M2ProteinHumans
Unknown
Antagonist
Details
TrihexyphenidylMuscarinic acetylcholine receptor M3ProteinHumans
Unknown
Antagonist
Details
TrihexyphenidylMuscarinic acetylcholine receptor M4ProteinHumans
Unknown
Antagonist
Details
TrihexyphenidylMuscarinic acetylcholine receptor M5ProteinHumans
Unknown
Antagonist
Details
Binding Properties
DrugTargetPropertyMeasurementpHTemperature (°C)
PirenzepineMuscarinic acetylcholine receptor M1Ki (nM)6.31N/AN/ADetails
TrihexyphenidylMuscarinic acetylcholine receptor M1Ki (nM)0.37N/AN/ADetails
TrihexyphenidylMuscarinic acetylcholine receptor M1Ki (nM)123.03N/AN/ADetails
TrihexyphenidylMuscarinic acetylcholine receptor M2Ki (nM)7.08N/AN/ADetails
TrihexyphenidylMuscarinic acetylcholine receptor M2Ki (nM)489.78N/AN/ADetails
TrihexyphenidylMuscarinic acetylcholine receptor M3Ki (nM)2.45N/AN/ADetails
TrihexyphenidylMuscarinic acetylcholine receptor M3Ki (nM)1288.25N/AN/ADetails
TrihexyphenidylMuscarinic acetylcholine receptor M4Ki (nM)0.83N/AN/ADetails
TrihexyphenidylMuscarinic acetylcholine receptor M4Ki (nM)269.15N/AN/ADetails